≪ View Page
  • Artikel anhören:
    • Der Dark Mode ist experimentel. Darstellungsfehler bitte melden!

    Unterschiede

    Hier werden die Unterschiede zwischen zwei Versionen angezeigt.

    Link zu dieser Vergleichsansicht

    medizin:offlabelmedikamente:studien [13.12.2025 11:20] – angelegt - Externe Bearbeitung 127.0.0.1medizin:offlabelmedikamente:studien [13.12.2025 18:03] (aktuell) – [Low Dose Naltrexon (LDN)] sven
    Zeile 8: Zeile 8:
       * [[https://doi.org/10.1080/21641846.2019.1692770|Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)]]   * [[https://doi.org/10.1080/21641846.2019.1692770|Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)]]
       * [[https://doi.org/10.1016/j.clinthera.2023.12.009|Low-dose Naltrexone Improves post–COVID-19 condition Symptoms]]   * [[https://doi.org/10.1016/j.clinthera.2023.12.009|Low-dose Naltrexone Improves post–COVID-19 condition Symptoms]]
     +  * [[https://pubmed.ncbi.nlm.nih.gov/40458265/|Low-Dose naltrexone restored TRPM3 ion channel function in natural killer cells from long COVID patients]]
     ==== Amifampridin ==== ==== Amifampridin ====
       * [[https://www.cureus.com/articles/218002-reduced-fatigue-symptoms-in-the-post-covid-syndrome-with-amifampridine-a-collective-casuistry-with-double-blind-discontinuation-trials#!/|Reduced Fatigue Symptoms in the Post-COVID Syndrome With Amifampridine: A Collective Casuistry With Double-Blind Discontinuation Trials]]   * [[https://www.cureus.com/articles/218002-reduced-fatigue-symptoms-in-the-post-covid-syndrome-with-amifampridine-a-collective-casuistry-with-double-blind-discontinuation-trials#!/|Reduced Fatigue Symptoms in the Post-COVID Syndrome With Amifampridine: A Collective Casuistry With Double-Blind Discontinuation Trials]]
    ⤴